Filgotinib Clinical Trials

3 actively recruiting trials

Also known as: GLPG0634, GS-6034, Jyseleca

Pipeline

Phase 1: 1Phase 4: 2

Top Sponsors

Universita di Verona1
R.Bos1
Alfasigma S.p.A.1

Indications

Arthritis3
Rheumatoid Arthritis2
Juvenile Idiopathic Arthritis1

Other3 trials

Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)

Phase 4

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

Phase 4

Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.